0 views
Rentschler Biopharma SE, a leading contract development and manufacturing organization (CDMO), specializes in biopharmaceuticals and advanced therapies for patients with serious and rare diseases. With facilities and offices around the world, Rentschler Biopharma operates in a highly regulated environment, necessitating robust operational security and data integrity across its global infrastructure.
Date: March 21, 2025